Detalhe da pesquisa
1.
Homologous and Heterologous Covid-19 Booster Vaccinations.
N Engl J Med
; 386(11): 1046-1057, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081293
2.
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med
; 383(20): 1920-1931, 2020 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32663912
3.
Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization.
Eur J Immunol
; 49(2): 266-276, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30548475
4.
Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31527037
5.
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.
Mol Ther
; 26(10): 2507-2522, 2018 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30078765
6.
Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.
Eur J Immunol
; 46(12): 2719-2729, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27701733
7.
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.
J Immunol
; 195(7): 3190-7, 2015 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26297758
8.
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.
J Immunol
; 193(6): 2911-8, 2014 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25086172
9.
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.
J Infect Dis
; 212(3): 495-504, 2015 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25637347
10.
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
J Immunol
; 191(5): 2514-2525, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23904160
11.
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.
Am J Respir Crit Care Med
; 199(8): 947-951, 2019 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30428263
12.
Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
Infect Immun
; 82(9): 3979-85, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25024362
13.
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Eur J Immunol
; 43(9): 2398-408, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23716300
14.
The importance of adjuvant formulation in the development of a tuberculosis vaccine.
J Immunol
; 188(5): 2189-97, 2012 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22291184
15.
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
J Infect Dis
; 207(8): 1242-52, 2013 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22891286
16.
Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
Int J Infect Dis
; 130 Suppl 1: S47-S51, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36963657
17.
SARS-CoV-2 infection and immune responses.
AIMS Microbiol
; 9(2): 245-276, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37091818
18.
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen.
Tuberculosis (Edinb)
; 138: 102302, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36586154
19.
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis.
Vaccines (Basel)
; 11(1)2023 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36679975
20.
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration.
Pharmaceuticals (Basel)
; 16(5)2023 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37242512